Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies

E-ISSN： 1873-5576|15|9|769-780

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.15, Iss.9, 2015-11, pp. : 769-780

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The therapeutic role of targeting protein kinase C in solid and hematologic malignancies

By Podar Klaus Raab Marc S Chauhan Dharminder Anderson Kenneth C

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1693-1707

Informa Healthcare

Access to resources Recommend Favorite

Ras as a therapeutic target in hematologic malignancies

By Alvarado Yesid Giles Francis J

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 271-284

Informa Healthcare

Access to resources Recommend Favorite

Strategies for Targeting IL-4 as a Novel Therapeutic Approach for the Treatment of Atopic Dermatitis

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 1, Iss. 1, 2002-04 ,pp. : 41-53

Bentham Science Publishers

Access to resources Recommend Favorite

The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2100-2110

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Vascular Endothelial Growth Factor and its Receptors in Haematological Malignancies

Current Cancer Drug Targets, Vol. 5, Iss. 8, 2005-12 ,pp. : 573-578

Bentham Science Publishers

Access to resources Recommend Favorite